Viewing nowCombinationTeloditan Tablet 40/5mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ilhwa Co., Ltd.

MFDS item code 201702542 · Approved 2017.05.24 · Insurance code 640903420
Treatment of essential hypertension not controlled with monotherapy
This medication is used to improve blood pressure in patients with essential hypertension who do not achieve sufficient control with monotherapy of either amlodipine or telmisartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine; however, a direct switch to this medicine may be considered if blood pressure is not adequately controlled with the individual components, as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. For patients taking telmisartan and amlodipine concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Use of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients aged 18 years and younger.
This drug can cause serious harm to the fetus, especially during the second and third trimesters, so it should not be used by women who are pregnant or may become pregnant. This drug should not be administered to patients with certain conditions, such as liver impairment, heart issues, hypotension, or poor kidney function. Patients with primary aldosteronism, aortic stenosis, liver impairment, gastrointestinal disorders, or renal artery hypertension should use this drug with special caution, and elderly patients should have their dosage adjusted or use it with care. Common side effects may include dizziness or peripheral edema, and serious side effects can occur rarely, so any unusual symptoms should be reported immediately to healthcare providers. This drug should not be started or continued during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible and switched to another treatment. Since hypotension may occur, patients with fluid or salt depletion should correct their condition before administration, and blood pressure and symptoms should be carefully monitored afterwards. This drug may elevate potassium levels in the blood, so patients at risk of hyperkalemia should have regular blood tests, and caution is needed when taking potassium supplements or medications containing potassium. Patients with impaired kidney function should be regularly monitored for kidney function and serum electrolyte levels during administration. In patients with heart disease, this drug may increase the risk of angina or myocardial infarction, so attention should be paid to symptom changes. This drug may cause drowsiness or dizziness, so caution is needed when driving or operating hazardous machinery. Interactions may occur when used in combination with other medications, so it is important to inform healthcare providers of any other medications being taken. Breastfeeding women should refrain from using this drug, and its safety and efficacy have not been sufficiently established in children or adolescents, so it is not recommended for use in these populations. In case of overdose, symptoms may include hypotension, dizziness, and cardiac function abnormalities, so immediate medical attention should be sought. This drug should be kept out of reach of children and stored in its original packaging with attention to moisture.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly closed container that protects it from light. Additionally, it should be stored at room temperature between 1 degree and 30 degrees Celsius to maintain its effectiveness and safety.
Biconvex oval double-coated tablet in white and light gray
30 tablets/box [10 tablets/Alu-Alu X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ilhwa Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.